TARGET AUDIENCE
This educational activity is intended for clinicians who have a role in the diagnosis, monitoring, and treatment of patients with Duchenne muscular dystrophy (DMD), including neurologists, neuromuscular specialists, pediatricians, geneticists, genetic counselors, physical and occupational therapists, nurse practitioners, and physician associates.

PROGRAM OVERVIEW
This activity is part of a national series addressing ongoing knowledge and competence gaps for DMD. The focus is on improving diagnosis and patient monitoring via multidisciplinary and interprofessional care coordination; increasing knowledge surrounding gene therapy clinical trial endpoints with a focus toward real world application; and an enhanced awareness of patient/caregiver perspectives and incorporation into clinical decision-making. 

Upon completion of this activity, the learners should be able to:

• Determine how multidisciplinary and interprofessional care coordination can improve early diagnosis and ongoing monitoring of patients with DMD
• Apply gene therapy clinical trial endpoints into real world patient management scenarios for DMD
• Incorporate patient/caregiver perspectives into clinical decision-making for DMD

FACULTY
Aravindhan Veerapandiyan, MD
Child Neurologist and Assistant Professor
University of Arkansas Medical Sciences

Craig Zaidman, MD
Professor of Neurology, Professor of Pediatrics
Division of Neuromuscular Medicine
Institute of Clinical and Translational Sciences
Washington University School of Medicine

PLANNING COMMITTEE
Aravindhan Veerapandiyan, MD
Child Neurologist and Assistant Professor
University of Arkansas Medical Sciences

Craig Zaidman, MD
Professor of Neurology, Professor of Pediatrics
Division of Neuromuscular Medicine
Institute of Clinical and Translational Sciences
Washington University School of Medicine

Kittredge White, BSc, MA, PA-C
Senior Medical Writer
The France Foundation

ACCREDITATION STATEMENT

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

CREDIT DESIGNATION

Physicians

The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The France Foundation designates this activity for 1.0 contact hours.

Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until June 29, 2024. PAs should only claim credit commensurate with the extent of their participation.

All other healthcare professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an independent medical educational grant from Sarepta Therapeutics, Inc.

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission